CXCL10 and COVID-19: Cytokine screening analysis performed simultaneously with metabolomic analysis revealed that CXCL10 levels were specifically elevated and significantly positively correlated with blood amino acid catabolite concentrations during the early stages of COVID-19 in severe outcome patients (Fig. 5a, e, f).